Coldstream Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
|
|||||
|
2025
Q1 | $404K | Sell |
|
|||||
|
2024
Q4 | $557K | Buy |
|
|||||
|
2024
Q3 | $452K | Buy |
|
|||||
|
2024
Q2 | $468K | Buy |
|
|||||
|
2024
Q1 | $463K | Buy |
|
|||||
|
2023
Q4 | $423K | Buy |
|
|||||
|
2023
Q3 | $263K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $283K | Sell |
|
|||||
|
2022
Q4 | $403K | Buy |
|
|||||
|
2022
Q2 | $305K | Buy |
|
|||||
|
2022
Q1 | $209K | Buy |
|